| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/03/2005 | US20050026192 Oligonucleotide synthesis with alternative solvents |
| 02/03/2005 | US20050026191 Nucleotide sequences coding interferon-inducible proteins in fibroblasts for use in diagnosis, prevention and treatment of cell proliferative, nervous system, glandular and inflammatory diseases |
| 02/03/2005 | US20050026190 Detection of high grade dysplasia in cervical cells |
| 02/03/2005 | US20050026189 Designing vector for use as tool in preventing aberrant cell proliferation; antiproliferfative agents; tissue targeted therapy |
| 02/03/2005 | US20050026188 Methods of identifying, characterizing and comparing organism communities |
| 02/03/2005 | US20050026186 Method for evaluating an inclination of a subject to lung cancer |
| 02/03/2005 | US20050026185 Biological signature of manufactured products |
| 02/03/2005 | US20050026183 Using methylation patterns of guanine and cytosine dinucleotides as a diagnostic and/or prognostic indicator of cell proliferfative disorders; genomic imprinting control regions (ICRs) |
| 02/03/2005 | US20050026182 Human CDNAS and proteins and uses thereof |
| 02/03/2005 | US20050026181 Bio bar-code |
| 02/03/2005 | US20050026180 Direct multiplex characterization of genomic DNA |
| 02/03/2005 | US20050026178 Allosteric probes and methods |
| 02/03/2005 | US20050026177 Preparing pharmaceutical grade plasmids for use as gene transfer tools in genetic engineering |
| 02/03/2005 | US20050026176 DNA probe design device and information processing method for DNA probe design |
| 02/03/2005 | US20050026174 Alternative heterocycles for DNA recognition |
| 02/03/2005 | US20050026171 Protecting luciferase enzymatic activity in bioassays via intoduction of detergents in reaction mixture; high throughput assays |
| 02/03/2005 | US20050026169 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 02/03/2005 | US20050026168 Using presence of allelic blood clotting factors as diagnostic indicator of cardiovascular disorders |
| 02/03/2005 | US20050026167 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| 02/03/2005 | US20050026166 Using structure specific nucleases as diagnostic tools in detection of preferential nucleotide sequences; clinical microbiology, blood screening, food safety, genetic disease diagnosis and prognosis |
| 02/03/2005 | US20050026164 Methods of genetic analysis of mouse |
| 02/03/2005 | US20050026163 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups |
| 02/03/2005 | US20050026162 Compositions and methods for the modification of gene expression |
| 02/03/2005 | US20050026161 Detecting non-nucleic acid analyte present in sample: comprising, contacting sample with non-nucleic acid analyte reporter conjugate, allow complex to form, elute and monitor for nucleic acid marker in sample; immunodiagnostics |
| 02/03/2005 | US20050026160 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 02/03/2005 | US20050026158 Methods of diagnosing and treating hepatic cell proliferative disorders |
| 02/03/2005 | US20050026157 Enzymatic fusion protein comprising cleavage and nuclear localization domain for use gene targeting tool in gene therapeutics |
| 02/03/2005 | US20050026156 Nucleotide sequences for use in detection, identification and classification of fish tissues |
| 02/03/2005 | US20050026154 Preparing diagnostic biopolymer arrays for use in gene expression analysis |
| 02/03/2005 | US20050026152 Methods of screening for schizophrenia |
| 02/03/2005 | US20050026150 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 02/03/2005 | US20050026149 Expression vector comprising chimeric nucleotide comprising nuclear, choloroplast and/or mitochondrial localization signals for use as tools in transfer of heterologous genes into preferential genomes |
| 02/03/2005 | US20050026147 Enzyme blend comprising DNA polymerase and repair enzymes for correcting apurinic/apyrimidinic (AP) damages in polynucleotide sequence |
| 02/03/2005 | US20050026146 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna |
| 02/03/2005 | US20050026144 Reverse transcription-polymerase chain reaction (RT-PCR) assays |
| 02/03/2005 | US20050026141 Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| 02/03/2005 | US20050026140 Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| 02/03/2005 | US20050026138 Identifying cell death induction modulators via ability of compound to prevent translocation of viron associated auxilliary protein (VPR) /apoptosis induction factor (AIF) multimeric protein to nucleus; treating cell proliferative and inflammatory disorders |
| 02/03/2005 | US20050026135 Rapid detection of live cells by detection of cylindrical microcolonies using visible light; cell propagation and analysis |
| 02/03/2005 | US20050025815 Protonated/acidified nucleic acids are effective as bactericidal and/or bacteriostatic agents |
| 02/03/2005 | US20050025779 Immunogenic gp120 polypeptides and polynucleotides; expression vectors and host cells; medical diagnosis; vaccines |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025762 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | US20050023156 Nanostructured material transport devices and their fabrication by application of molecular coatings to nanoscale channels |
| 02/03/2005 | US20050023152 test strip defining capillary passageways hvaing electrodes for measuring concentration of analytes in the samples; analysis apparatus |
| 02/03/2005 | US20050023137 Biosensor with multiple electrical functionalities |
| 02/03/2005 | DE202004013170U1 Mold indicator, detecting e.g. pathogenic spores suspended in room air, comprises container for sterile cellulosic material, dye and water-absorbent substrate |
| 02/03/2005 | DE10332728A1 Analysis of nucleic acids by hybridization, requires nucleic acid hybrids in first buffer to have higher melting point than in second buffer |
| 02/03/2005 | DE10328813A1 Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA-Sequenzen mittels triplexbildender Oligomere A method for the examination of cytosine methylations in DNA sequences by means triplexbildender oligomers |
| 02/03/2005 | DE10012670B4 Mikrodissektion von Fluoreszenz in situ hybridisierten chromosomalen Material (FISH-MD) Microdissection of fluorescence in situ hybridized chromosomal material (FISH-MD) |
| 02/03/2005 | CA2780958A1 Determining the sequence of a polynucleotide |
| 02/03/2005 | CA2534633A1 Biomarker panel for colorectal cancer |
| 02/03/2005 | CA2534438A1 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| 02/03/2005 | CA2533691A1 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 02/03/2005 | CA2533542A1 Method of determining sperm capacitation |
| 02/03/2005 | CA2533119A1 Method for the reverse transcription and/or amplification of nucleic acids |
| 02/03/2005 | CA2532809A1 Plant centromere compositions |
| 02/03/2005 | CA2532722A1 Cystatin sn (cst1) and other markers for detection of gastric cancer |
| 02/03/2005 | CA2532394A1 Rg1 antibodies and uses thereof |
| 02/03/2005 | CA2532084A1 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 02/03/2005 | CA2532036A1 Methods for identifying cell surface receptor protein modulators |
| 02/03/2005 | CA2532035A1 Fugetactic proteins, compositions and methods of use |
| 02/03/2005 | CA2531492A1 Compositions for purifying and crystallizing molecules of interest |
| 02/03/2005 | CA2531105A1 Method and compositions for detection and enumeration of genetic variations |
| 02/03/2005 | CA2530168A1 Method of judging risk for drug-induced granulocytopenia |
| 02/03/2005 | CA2528440A1 Replikin peptides and uses thereof |
| 02/03/2005 | CA2528043A1 Marks as modifiers of the pten pathway and methods of use |
| 02/03/2005 | CA2527683A1 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 02/03/2005 | CA2526240A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 02/03/2005 | CA2516783A1 Human lymphocyte vaccine adjuvant |
| 02/02/2005 | EP1502962A2 Methods for assessing and treating cancer |
| 02/02/2005 | EP1502961A1 New detection format for hot start real time polymerase chain reaction |
| 02/02/2005 | EP1502960A1 Method of detecting rheumatoid arthritis by detecting overexpression of wnt |
| 02/02/2005 | EP1502959A1 A procedure for the creation and use of DNA-recognition element libraries in vivo in relation to gene expression |
| 02/02/2005 | EP1502958A1 New detection format for hot start real time polymerase chain reaction |
| 02/02/2005 | EP1502957A1 Castable diffusion membrane for enzyme-based sensor application |
| 02/02/2005 | EP1502948A1 Ammonia-oxidizing bacteria |
| 02/02/2005 | EP1502222A2 A distributed system for epigenetic based prediction of complex phenotypes |
| 02/02/2005 | EP1502112A2 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 02/02/2005 | EP1502110A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 02/02/2005 | EP1502109A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) |
| 02/02/2005 | EP1502108A1 Device and method for monitoring leukocyte migration |
| 02/02/2005 | EP1502107A2 Treating cancer |
| 02/02/2005 | EP1502106A1 Bio-spectral imaging system and methods for diagnosing cell disease state |
| 02/02/2005 | EP1502105A2 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity |
| 02/02/2005 | EP1502102A2 Compounds and methods for analyzing the proteome |
| 02/02/2005 | EP1502101A2 Rapid and sensitive detection of cells and viruses |
| 02/02/2005 | EP1501949A2 Ssh based methods for identifying and isolating unique nucleic acid sequences |
| 02/02/2005 | EP1501948A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/02/2005 | EP1501947A2 Method of creating a library of bacterial clones with varying levels of gene expression |
| 02/02/2005 | EP1501946A2 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases |
| 02/02/2005 | EP1501944A2 Amplification of dna to produce single-stranded product of defined sequence and length |
| 02/02/2005 | EP1501943A2 Method to enhance homologous recombination |
| 02/02/2005 | EP1501942A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/02/2005 | EP1501941A1 Antisense modulation of jagged 2 expression |
| 02/02/2005 | EP1501940A1 Method for phenotyping using nmr spectroscopy |
| 02/02/2005 | EP1501938A2 Comparative phenotype analysis of cells, including testing of biologically active compounds |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501928A1 Assay for melanogenesis |